NASDAQ:SGRY - Surgery Partners Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$14.15 -1.00 (-6.60 %)
(As of 07/18/2018 04:00 PM ET)
Previous Close$15.15
Today's Range$14.05 - $15.20
52-Week Range$7.10 - $21.75
Volume738,962 shs
Average Volume217,120 shs
Market Capitalization$743.47 million
P/E Ratio-16.85
Dividend YieldN/A
Beta1.85
Surgery Partners logoSurgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 12, 2018, the company operated approximately 180 locations in 32 states, including ambulatory surgery centers, surgical hospitals, a diagnostic laboratory, multi-specialty physician practices, and urgent care facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900

Debt

Debt-to-Equity Ratio1.63
Current Ratio1.72
Quick Ratio1.55

Price-To-Earnings

Trailing P/E Ratio-16.85
Forward P/E Ratio-25.73
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.34 billion
Price / Sales0.52
Cash Flow$0.2995 per share
Price / Cash47.25
Book Value$27.41 per share
Price / Book0.52

Profitability

EPS (Most Recent Fiscal Year)($0.84)
Net Income$-52,980,000.00
Net Margins-5.13%
Return on Equity-1.90%
Return on Assets-0.50%

Miscellaneous

Employees10,600
Outstanding Shares48,910,000
Market Cap$743.47

The Truth About Cryptocurrencies

Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

How will Surgery Partners' stock buyback program work?

Surgery Partners declared that its Board of Directors has approved a share repurchase plan on Saturday, December 16th 2017, which allows the company to buyback $50,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to buy shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company's leadership believes its shares are undervalued.

How were Surgery Partners' earnings last quarter?

Surgery Partners Inc (NASDAQ:SGRY) released its quarterly earnings results on Wednesday, May, 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.05. The firm earned $417.37 million during the quarter, compared to analysts' expectations of $410.79 million. Surgery Partners had a negative net margin of 5.13% and a negative return on equity of 1.90%. The company's quarterly revenue was up 45.8% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.06) earnings per share. View Surgery Partners' Earnings History.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Surgery Partners.

What price target have analysts set for SGRY?

8 Wall Street analysts have issued 12-month price objectives for Surgery Partners' shares. Their predictions range from $15.00 to $19.00. On average, they expect Surgery Partners' stock price to reach $17.6667 in the next year. This suggests a possible upside of 24.9% from the stock's current price. View Analyst Ratings for Surgery Partners.

What is the consensus analysts' recommendation for Surgery Partners?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Surgery Partners' key competitors?

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the folowing people:
  • Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 47)
  • Mr. Dennis Dean, Sr. VP & Corp. Controller (Age 46)
  • Mr. Clifford G. Adlerz, Consultant & Director (Age 64)
  • Ms. Teresa F. Sparks, Consultant (Age 49)
  • Mr. Wayne Scott DeVeydt, CEO & Director (Age 48)

Has Surgery Partners been receiving favorable news coverage?

Media coverage about SGRY stock has trended somewhat positive on Wednesday, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Surgery Partners earned a media sentiment score of 0.12 on Accern's scale. They also assigned media stories about the company an impact score of 46.18 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a number of of retail and institutional investors. Top institutional investors include NN Investment Partners Holdings N.V. (11.29%) and Bank of Montreal Can (0.02%). Company insiders that own Surgery Partners stock include HIG Surgery Centers, Llc and Jennifer Baldock. View Institutional Ownership Trends for Surgery Partners.

Which institutional investors are buying Surgery Partners stock?

SGRY stock was purchased by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V. and Bank of Montreal Can. View Insider Buying and Selling for Surgery Partners.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $14.15.

How big of a company is Surgery Partners?

Surgery Partners has a market capitalization of $743.47 million and generates $1.34 billion in revenue each year. The company earns $-52,980,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Surgery Partners employs 10,600 workers across the globe.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]


MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  143 (Vote Outperform)
Underperform Votes:  182 (Vote Underperform)
Total Votes:  325
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.